Vandusen, Brian
Vandusen, Brian was paid $1.11M by Medicaid between Feb 2018 and Nov 2024, across 6 billing codes. Its largest line is V2020, Frames, purchases — 25% of everything it billed.
33Billing provider infoVANDUSEN, BRIAN
BANNING, CA 92220
BANNING, CA 92220
33aNPI1437338407assigned 10/26/2007
33bProvider typeOptometrist
28Total paid$1.11M
24GClaims49,323
24DCodes billed6
24AFirst – last monthFeb 2018 – Nov 2024
Compared with peers
Next to other Optometrist providers in California
Rank by total paid#61 of 1,899
Median peer was paid$23K
This provider vs. median49×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 5,419 | $118K | |
| 2019 | 7,040 | $153K | |
| 2020 | 5,926 | $131K | |
| 2021 | 7,551 | $163K | |
| 2022 | 7,844 | $175K | |
| 2023 | 8,662 | $201K | |
| 2024incomplete | 6,881 | $165K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| V2020 | Frames, purchases | 25% | 13,083 | 13,026 | $279K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 22% | 7,042 | 7,007 | $247K |
| 92340 | Fitting of spectacles, except for aphakia; monofocal | 21% | 10,300 | 10,243 | $229K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | 17% | 4,634 | 4,616 | $183K |
| 92015 | Determination of refractive state | 8.4% | 11,804 | 11,746 | $93K |
| 92341 | 6.8% | 2,460 | 2,458 | $76K |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.